These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21893098)

  • 21. Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system.
    Widman DG; Ishikawa T; Fayzulin R; Bourne N; Mason PW
    Vaccine; 2008 May; 26(22):2762-71. PubMed ID: 18423946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
    Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK
    Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge.
    De Filette M; Soehle S; Ulbert S; Richner J; Diamond MS; Sinigaglia A; Barzon L; Roels S; Lisziewicz J; Lorincz O; Sanders NN
    PLoS One; 2014; 9(2):e87837. PubMed ID: 24503579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction and characterization of subgenomic replicons of New York strain of West Nile virus.
    Shi PY; Tilgner M; Lo MK
    Virology; 2002 May; 296(2):219-33. PubMed ID: 12069521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01.
    Iyer AV; Pahar B; Boudreaux MJ; Wakamatsu N; Roy AF; Chouljenko VN; Baghian A; Apetrei C; Marx PA; Kousoulas KG
    Vaccine; 2009 Feb; 27(6):893-903. PubMed ID: 19070640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
    Samina I; Havenga M; Koudstaal W; Khinich Y; Koldijk M; Malkinson M; Simanov M; Perl S; Gijsbers L; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2007 Nov; 25(49):8338-45. PubMed ID: 17977629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery.
    Tinker JK; Yan J; Knippel RJ; Panayiotou P; Cornell KA
    Toxins (Basel); 2014 Apr; 6(4):1397-418. PubMed ID: 24759174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
    Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P
    J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection.
    Chang GJ; Davis BS; Stringfield C; Lutz C
    Vaccine; 2007 Mar; 25(12):2325-30. PubMed ID: 17224209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999).
    Yang JS; Kim JJ; Hwang D; Choo AY; Dang K; Maguire H; Kudchodkar S; Ramanathan MP; Weiner DB
    J Infect Dis; 2001 Oct; 184(7):809-16. PubMed ID: 11550123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives.
    Seregin A; Nistler R; Borisevich V; Yamshchikov G; Chaporgina E; Kwok CW; Yamshchikov V
    Virology; 2006 Dec 5-20; 356(1-2):115-25. PubMed ID: 16935318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of West Nile virus DNA-plasmid vaccination on response to live virus challenge in red-tailed hawks (Buteo jamaicensis).
    Redig PT; Tully TN; Ritchie BW; Roy AF; Baudena MA; Chang GJ
    Am J Vet Res; 2011 Aug; 72(8):1065-70. PubMed ID: 21801064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a vaccine vector based on a subgenomic replicon of porcine reproductive and respiratory syndrome virus.
    Huang Q; Yao Q; Fan H; Xiao S; Si Y; Chen H
    J Virol Methods; 2009 Sep; 160(1-2):22-8. PubMed ID: 19464739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine.
    Lim CK; Takasaki T; Kotaki A; Kurane I
    Virology; 2008 Apr; 374(1):60-70. PubMed ID: 18221765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine.
    Davis EG; Zhang Y; Tuttle J; Hankins K; Wilkerson M
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):293-301. PubMed ID: 18838173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain.
    Welte T; Xie G; Wicker JA; Whiteman MC; Li L; Rachamallu A; Barrett A; Wang T
    Vaccine; 2011 Jun; 29(29-30):4853-61. PubMed ID: 21549792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of capsid protein in trans enhances production of single-round infectious particles by West Nile virus DNA vaccine candidate.
    Roby JA; Bielefeldt-Ohmann H; Prow NA; Chang DC; Hall RA; Khromykh AA
    J Gen Virol; 2014 Oct; 95(Pt 10):2176-2191. PubMed ID: 24958626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers.
    Pierce KK; Whitehead SS; Kirkpatrick BD; Grier PL; Jarvis A; Kenney H; Carmolli MP; Reynolds C; Tibery CM; Lovchik J; Janiak A; Luke CJ; Durbin AP; Pletnev AG
    J Infect Dis; 2017 Jan; 215(1):52-55. PubMed ID: 28077583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine.
    Nelson MH; Winkelmann E; Ma Y; Xia J; Mason PW; Bourne N; Milligan GN
    Vaccine; 2010 Dec; 29(2):174-82. PubMed ID: 21055493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.